Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Frontiers in Bioscience - Elite is Scopus-indexed (Q2, CiteScore 5.4), DOAJ. Published by IMR Press Limited.
Checked against the index lists dated .
ISSN 1945-0494Verify ISSN ↗1945-0508Verify ISSN ↗
Publisher: IMR Press Limited
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry, Genetics and Molecular Biology (all) | 67 / 223 | 70th | Q2 |
| Immunology and Microbiology (all) | 22 / 63 | 65th | Q2 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q2, CiteScore 5.4.
Frontiers in Bioscience - Elite is Q2 in Biochemistry, Genetics and Molecular Biology (all) (rank 67 of 223) and Q2 in Immunology and Microbiology (all) (rank 22 of 63), by CiteScore 2025.
Frontiers in Bioscience - Elite is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 5.4, quartile Q2, 70th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.777, quartile Q2, with an H-index of 64.
The publisher lists an article processing charge of about US$500 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Frontiers in Bioscience - Elite is published by IMR Press Limited. Its print ISSN is 1945-0494 and its online ISSN is 1945-0508.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Frontiers in Bioscience - Elite has an h-index of 76 and a 2-year mean of 6.51 citations per paper (OpenAlex). Its Scopus CiteScore is 5.4, quartile Q2. On 2-year citations it ranks #21 of 221 Scopus journals in Biochemistry, Genetics and Molecular Biology (all).
Frontiers in Bioscience - Elite published 32 papers in 2025; its busiest recent year was 2024 with 40. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2024–2026), authors are most often from Russia (15.5%), United States (13.5%) and India (13.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (1.5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.